RECORD // Company

Longevity Health Holdings, Inc.

Formerly: Carmell Corp; ALPHA HEALTHCARE ACQUISITION CORP III

Built 2026-11-22T03:18:45Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)

3 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-06-30, filed 2026-08-14 · accession 0001437749-26-028043

ItemValuePeriodFormFiledAccessionReport
Revenue$395,9913 months ended 2026-06-3010-Q2026-08-140001437749-26-0280432026-11-22 03:18 UTCReport an error
Net income (loss)$-1,883,2903 months ended 2026-06-3010-Q2026-08-140001437749-26-0280432026-11-22 03:18 UTCReport an error
Cash and cash equivalents$35,471at 2026-06-3010-Q2026-08-140001437749-26-0280432026-11-22 03:18 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001842939
Ticker
XAGE
EIN
861645738
CUSIP
142922129
Record ID
sx:sec:0001842939

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

30 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profile2026-11-22 03:18 UTCReport an error
SIC industry2840 Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics2026-11-16SEC EDGAR company profile2026-11-22 03:18 UTCReport an error
State of incorporationDE2026-11-16SEC EDGAR company profile2026-11-22 03:18 UTCReport an error
Fiscal year end (MMDD)12312026-11-16SEC EDGAR company profile2026-11-22 03:18 UTCReport an error
Business address2403 SIDNEY STREET, SUITE 300, PITTSBURGH, PA, 152032026-11-16SEC EDGAR company profile2026-11-22 03:18 UTCReport an error
ExchangesOTC, OTC2026-11-16SEC EDGAR company profile2026-11-22 03:18 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$1,912,8112025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-22 03:18 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-6,905,2822025-12-3110-K, XBRL NetIncomeLoss2026-11-22 03:18 UTCReport an error
Total assets (at 2025-12-31)$2,367,0272025-12-3110-K, XBRL Assets2026-11-22 03:18 UTCReport an error
Stockholders' equity (at 2025-12-31)$-5,866,8732025-12-3110-K, XBRL StockholdersEquity2026-11-22 03:18 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$706,7402025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 03:18 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-3,329,2662025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 03:18 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$14,2252025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 03:18 UTCReport an error
Operating lease liabilities (at 2025-12-31)$309,9382025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 03:18 UTCReport an error
Form D total offering amount (D filed 2026-03-30)$200,0002026-03-30D2026-11-22 03:18 UTCReport an error
Form D total amount sold (D filed 2026-03-30)$200,0002026-03-30D2026-11-22 03:18 UTCReport an error
Form D industry groupOther Health Care2026-03-30D2026-11-22 03:18 UTCReport an error
Form D revenue rangeDecline to Disclose2026-03-30D2026-11-22 03:18 UTCReport an error
Form D date of first sale2026-03-162026-03-30D2026-11-22 03:18 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-09-08)On September 8, 2026, the Company issued a press release announcing that the Company entered into a new securities purchase agreement with Puritan Partners LLC. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.2026-09-08SEC EDGAR 8-K 0001437749-26-029755 (text as filed, excerpt)2026-11-22 03:18 UTCReport an error
8-K Item 1.01, Entry into a Material Definitive Agreement (filed 2026-09-04)The Purchase Agreement and the Note On August 31, 2026, Longevity Health Holdings, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Puritan Partners LLC (“Puritan”), an existing investor in the Company, pursuant to which the Company issued and sold to Puritan a 10% Senior Secured Convertible Note due February 29, 2028, in the original principal amount of $416,667 (the “Note”), reflecting a 10% original issue discount, for a purchase price of $375,000. The proceeds from the Note will be used for working capital purposes to the extent not in contravention of the Settlement Agreement, dated August 13, 2026, by and among the Company, Puritan and…2026-09-04SEC EDGAR 8-K 0001437749-26-029714 (text as filed, excerpt)2026-11-22 03:18 UTCReport an error
8-K Item 2.03, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (filed 2026-09-04)The disclosure set forth under Item 1.01 above regarding the Note is incorporated herein by reference. The issuance of the Note by the Company constitutes the creation of a direct financial obligation of the Company in the original principal amount of $416,667.2026-09-04SEC EDGAR 8-K 0001437749-26-029714 (text as filed, excerpt)2026-11-22 03:18 UTCReport an error
8-K Item 3.02, Unregistered Sales of Equity Securities (filed 2026-09-04)The disclosure set forth under Item 1.01 above is incorporated herein by reference. The Note, and the shares of Common Stock issuable upon conversion thereof, were and will be offered and sold by the Company to Puritan without registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder, based in part on the representations of Puritan in the Purchase Agreement, including that Puritan is an “accredited investor” as defined in Rule 501(a) of Regulation D. No general solicitation or general advertising was used in…2026-09-04SEC EDGAR 8-K 0001437749-26-029714 (text as filed, excerpt)2026-11-22 03:18 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-08-17)On August 17, 2026, the Company issued a press release announcing the settlement of litigation with Puritan Partners LLC. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.2026-08-17SEC EDGAR 8-K 0001437749-26-028120 (text as filed, excerpt)2026-11-22 03:18 UTCReport an error
8-K Item 1.01, Entry into a Material Definitive Agreement (filed 2026-08-14)On August 13, 2026, Longevity Health Holdings, Inc. (the “Company”) and its subsidiary Carmell Regen Med Corporation (“Carmell Regen”) entered into a Settlement Agreement (the “Settlement Agreement”) with Puritan Partners LLC (“Puritan”), resolving the litigation captioned Puritan Partners LLC v. Carmell Regen Med Corporation, et al., Index No. 655566/2023, pending in the Supreme Court of the State of New York, County of New York (the “Action”), which related to a Securities Purchase Agreement dated January 19, 2022, a 10% Original Issue Discount Senior Secured Convertible Note due January 19, 2023 in the original principal amount of $1,250,000 issued by Carmell Regen to Puritan (the…2026-08-14SEC EDGAR 8-K 0001437749-26-028011 (text as filed, excerpt)2026-11-22 03:18 UTCReport an error
8-K Item 1.02, Termination of a Material Definitive Agreement (filed 2026-08-14)The information set forth in Item 1.01 above is incorporated herein by reference. In connection with the transactions described in Item 1.01, the Existing Note and the Warrant were terminated and canceled in exchange for the Initial Note and the Additional Note, respectively.2026-08-14SEC EDGAR 8-K 0001437749-26-028011 (text as filed, excerpt)2026-11-22 03:18 UTCReport an error
8-K Item 2.03, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (filed 2026-08-14)The information set forth in Item 1.01 above is incorporated herein by reference. The Initial Note and the Additional Note bear interest at a rate of 10% per annum and mature on February 5, 2028, subject to acceleration upon the occurrence of an Event of Default (as defined in the Notes). The Notes are convertible into shares of the Company’s common stock at an initial conversion price of $0.50 per share, subject to a lower Alternative Conversion Price, at Puritan’s election, equal to 80% of the average of the closing trade prices of the Company’s common stock over the five trading days preceding the applicable conversion date if the closing trade price is then below the conversion price.…2026-08-14SEC EDGAR 8-K 0001437749-26-028011 (text as filed, excerpt)2026-11-22 03:18 UTCReport an error
8-K Item 3.02, Unregistered Sales of Equity Securities (filed 2026-08-14)The information set forth in Item 1.01 and Item 2.03 above is incorporated herein by reference. The Initial Note and the Additional Note were issued to Puritan in exchange for the Existing Note and the Warrant, respectively, in transactions exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), in reliance on Section 3(a)(9) thereof and/or such other exemption as the Company determined to be applicable, including Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D thereunder. No general solicitation was used, and no underwriting discounts or commissions were paid, in connection with the issuance of the Notes. The Company…2026-08-14SEC EDGAR 8-K 0001437749-26-028011 (text as filed, excerpt)2026-11-22 03:18 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-08-14)As described in Item 1.01 above, on August 13, 2026, the Company and Carmell Regen entered into the Settlement Agreement with Puritan to resolve the Action. Pursuant to the Settlement Agreement, the parties agreed to file a stipulation dismissing the Action without prejudice within three business days following execution of the Settlement Agreement. Forward-Looking Statements. This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the anticipated closing and effects of the transactions described herein, the Company’s expected registration and repayment obligations, and…2026-08-14SEC EDGAR 8-K 0001437749-26-028011 (text as filed, excerpt)2026-11-22 03:18 UTCReport an error
Largest institutional holder #1 (13F as filed): DRW Securities, LLC$3,6802026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 03:18 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.